Metraipolis › archive › dc_76d709edbe61

Opportunities and Challenges of mRNA and VLP Technologies for Pan-Flavivirus Vaccine Development: Focus on Conserved Quaternary Epitope Conformations — Europe PMC PMID:41596723

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41596723
DOI
10.3390/ijms27021081
License (as archived)
solo-consultazione
Archived
2026-11-06T15:53:55.430Z
SHA-256 of the archived text
9c469e9b4634e68dc933781befb273528cff2d437d652e4a897e76d603d22534
Stable URL of this page
https://metraipolis.com/documento/dc_76d709edbe61

How to cite

Opportunities and Challenges of mRNA and VLP Technologies for Pan-Flavivirus Vaccine Development: Focus on Conserved Quaternary Epitope Conformations — Europe PMC PMID:41596723 — Europe PMC (en), https://europepmc.org/article/MED/41596723 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_76d709edbe61 (Metraipolis archive dc_76d709edbe61, sha256 9c469e9b4634e68dc933781befb273528cff2d437d652e4a897e76d603d22534)
BibTeX
@misc{dc76d709edbe61,
  title = {Opportunities and Challenges of mRNA and VLP Technologies for Pan-Flavivirus Vaccine Development: Focus on Conserved Quaternary Epitope Conformations — Europe PMC PMID:41596723},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41596723},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_76d709edbe61; sha256 9c469e9b4634e68dc933781befb273528cff2d437d652e4a897e76d603d22534},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41596723. Agents can read the archived copy with the MCP tool read_document.